Cargando…

Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma

Immune checkpoint therapy has resulted in minimal clinical response in many pediatric cancers. We sought to understand the influence of immune checkpoint inhibition using anti-PD-1 and anti-CTLA-4 antibodies individually, in combination, and after chemotherapy on immune responses in minimal and esta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirinbak, Soheila, Chan, Randall Y., Shahani, Shilpa, Muthugounder, Sakunthala, Kennedy, Rebekah, Hung, Long T., Fernandez, G. Esteban, Hadjidaniel, Michael D., Moghimi, Babak, Sheard, Michael A., Epstein, Alan L., Fabbri, Muller, Shimada, Hiroyuki, Asgharzadeh, Shahab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801125/ https://www.ncbi.nlm.nih.gov/pubmed/33489468 http://dx.doi.org/10.1080/2162402X.2020.1838140

Ejemplares similares

Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC
por: Hadjidaniel, Michael D., et al.
Publicado: (2017)

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
por: Moghimi, Babak, et al.
Publicado: (2021)

MODL-27. MEK INHIBITION WITH TRAMETINIB SLOWS PROGRESSION OF MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR IN ORTHOTOPIC XENOGRAFT MURINE MODEL
por: Mushrif, Sujata, et al.
Publicado: (2020)

Fibroblasts and macrophages cooperate to create a pro-tumorigenic and immune resistant environment via activation of TGF-β/IL-6 pathway in neuroblastoma
por: Louault, Kevin, et al.
Publicado: (2022)

TNF Blockade Maintains an IL-10(+) Phenotype in Human Effector CD4(+) and CD8(+) T Cells
por: Roberts, Ceri A., et al.
Publicado: (2017)

Enhancing Natural Killer and CD8(+) T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8(+) T Cells with HLA-E Monospecific Monoclonal Antibodies
por: Ravindranath, Mepur H., et al.
Publicado: (2019)

Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
por: Xu, Yibing, et al.
Publicado: (2013)

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma
por: Tang, Xao X., et al.
Publicado: (2021)

Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

CD28/CD154 Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell Expansion
por: Rigby, Mark R., et al.
Publicado: (2008)

Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma
por: Lascano, Danny, et al.
Publicado: (2023)

Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)
por: Ravindranath, Mepur H., et al.
Publicado: (2009)

CD154 Blockade Alters Innate Immune Cell Recruitment and Programs Alloreactive CD8(+) T Cells into KLRG-1(high) Short-Lived Effector T Cells
por: Ferrer, Ivana R., et al.
Publicado: (2012)

CD25(high) Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
por: Fattori, Stéphane, et al.
Publicado: (2023)

Rapid Effector Function in CD8(+) Memory T Cells
por: Lalvani, Ajit, et al.
Publicado: (1997)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Regulation of CD4(+) and CD8(+) Effector Responses by Sprouty-1
por: Collins, Sam, et al.
Publicado: (2012)

CD146 is a potential immunotarget for neuroblastoma
por: Obu, Satoshi, et al.
Publicado: (2021)

Use of CD200 blockade inhibitor to enhance glioma immunotherapy
por: Mesias, Elisabet, et al.
Publicado: (2015)

Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L
por: Airoldi, I, et al.
Publicado: (2003)

Restoration of CD28 Expression in CD28(−) CD8(+) Memory Effector T Cells Reconstitutes Antigen-induced IL-2 Production
por: Topp, Max S., et al.
Publicado: (2003)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
por: Choe, Deborah, et al.
Publicado: (2023)

Heterogeneity of human effector CD4(+ )T cells
por: Annunziato, Francesco, et al.
Publicado: (2009)

Protection by and maintenance of CD4 effector memory and effector T cell subsets in persistent malaria infection
por: Opata, Michael M., et al.
Publicado: (2018)

Expanded antigen-experienced CD160(+)CD8(+)effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia
por: Bozorgmehr, Najmeh, et al.
Publicado: (2021)

Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+ T Effector Memory Lymphocytes
por: Hu, Lina, et al.
Publicado: (2013)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2
por: Metelitsa, Leonid S., et al.
Publicado: (2004)

Notch controls effector CD8(+) T cell differentiation
por: Duval, Frédéric, et al.
Publicado: (2015)

Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques
por: Tolbert, William D., et al.
Publicado: (2022)

CD22 blockade restores homeostatic microglial phagocytosis in aging brains
por: Pluvinage, John V., et al.
Publicado: (2019)

Antibody blockade of CD96 by distinct molecular mechanisms
por: Lee, Peter S., et al.
Publicado: (2021)

NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4(+) T Cells
por: Hainberger, Daniela, et al.
Publicado: (2020)

The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR(+) CD8(+) effector state and its deletion improves checkpoint blockade
por: McClory, Susan E., et al.
Publicado: (2023)

The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR(+) CD8(+) effector state, and its deletion improves checkpoint blockade
por: McClory, Susan E., et al.
Publicado: (2023)

Kinetics of CD4(+) T Helper and CD8(+) Effector T Cell Responses in Acute Dengue Patients
por: Manh, Dao Huy, et al.
Publicado: (2020)

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
por: Banchereau, Romain, et al.
Publicado: (2021)

Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8(+) T Cells
por: Wolint, Petra, et al.
Publicado: (2004)

Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels
por: Heeren, A. M., et al.
Publicado: (2019)

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dkvralsijienr5jlm2shvp4mqr